Brain and Nervous System, Phase II

A Phase II Double-blind, RandomizEd, Prospective, Placebo Controlled STudy of NanO2TM Combined With Radiation and Temozolomide in Patients With Newly-diagnosed Glioblastoma multiformE: RESTORE

Volunteers
Health Professionals

What is the purpose of this trial?

This clinical trial is testing the safety and efficacy of NanO2TM administered via intravenous infusion in combination with standard radiation and chemotherapy.

NanO2TM is being developed to increase the amount of oxygen delivered to tumors which is hoped to increase the effectiveness of radiation therapy.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Amy L. Rodrigues

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Nicholas Blondin, MD
Associate Professor

Sub-Investigators

Last Updated
03/16/2025
Study HIC
#2000037963